{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:20:54Z","timestamp":1790983254749,"version":"4.1.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00467-018-3893-7","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T08:08:12Z","timestamp":1519891692000},"page":"45-59","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Acute kidney injury in children with chronic liver disease"],"prefix":"10.1007","volume":"34","author":[{"given":"Akash","family":"Deep","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romit","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bipin","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,1]]},"reference":[{"key":"3893_CR1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00000441-186304000-00002","volume":"45","author":"A Flint","year":"1863","unstructured":"Flint A (1863) Clinical report on hydro-peritoneum based on an analysis of forty-six cases. Am J Med Sci 45:306\u2013339","journal-title":"Am J Med Sci"},{"key":"3893_CR2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ajmg.a.34369","volume":"158A","author":"BM Kamath","year":"2012","unstructured":"Kamath BM, Podkameni G, Hutchinson AL, Leonard LD, Gerfen J, Krantz ID, Piccoli DA, Spinner NB, Loomes KM, Meyers K (2012) Renal anomalies in Alagille syndrome: a disease-defining feature. Am J Med Genet A 158A:85\u201389","journal-title":"Am J Med Genet A"},{"key":"3893_CR3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00467-015-3185-4","volume":"31","author":"E Park","year":"2016","unstructured":"Park E, Lee JM, Ahn YH, Kang HG, Ha IIS, Lee JH, Park YS, Kim NK, Park WY, Cheong HI (2016) Hepatorenal fibrocystic diseases in children. Pediatr Nephrol 31:113\u2013119","journal-title":"Pediatr Nephrol"},{"key":"3893_CR4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/petr.12705","volume":"20","author":"SE Khorsandi","year":"2016","unstructured":"Khorsandi SE, Samyn M, Hassan A, Vilca-Melendez H, Waller S, Shroff R, Koffman G, Van't Hoff W, Baker A, Dhawan A, Heaton N (2016) An institutional experience of pre-emptive liver transplantation for pediatric primary hyperoxaluria type 1. Pediatr Transplant 20:523\u2013529","journal-title":"Pediatr Transplant"},{"key":"3893_CR5","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10545-015-9840-x","volume":"38","author":"S K\u00f6lker","year":"2015","unstructured":"K\u00f6lker S, Valayannopoulos V, Burlina AB, Sykut-Cegielska J, Wijburg FA, Teles Zeman J, Dionisi-Vici C, Bari\u0107 I, Karall D, Arnoux JB, Avram P, Baumgartner MR, Blasco-Alonso J, Boy SP, Rasmussen MB, Burgard P, Chabrol B, Chakrapani A, Chapman K, Cort\u00e8s I, Saladelafont E, Couce ML, de Meirleir L, Dobbelaere D, Furlan F, Gleich F, Gonz\u00e1lez MJ, Gradowska W, Gr\u00fcnewald S, Honzik T, H\u00f6rster F, Ioannou H, Jalan A, H\u00e4berle J, Haege G, Langereis E, de Lonlay P, Martinelli D, Matsumoto S, M\u00fchlhausen C, Murphy E, de Baulny HO, Ortez C, Pedr\u00f3n CC, Pintos-Morell G, Pena-Quintana L, Ramad\u017ea DP, Rodrigues E, Scholl-B\u00fcrgi S, Sokal E, Summar ML, Thompson N, Vara R, Pinera IV, Walter JH, Williams M, Lund AM, Garcia-Cazorla A (2015) The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype. J Inherit Metab Dis 38:1059\u20131074","journal-title":"J Inherit Metab Dis"},{"key":"3893_CR6","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.transproceed.2006.08.156","volume":"38","author":"Y Wei","year":"2006","unstructured":"Wei Y, Zhang L, Lin H, Li J, Li B, Yan L, Wen T, Zeng Y, Lu S (2006) Factors related to post-liver transplantation acute renal failure. Transplant Proc 38:2982\u20132984","journal-title":"Transplant Proc"},{"key":"3893_CR7","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","volume":"48","author":"G Garcia-Tsao","year":"2008","unstructured":"Garcia-Tsao G, Parikh CR, Viola A (2008) Acute kidney injury in cirrhosis. Hepatology 48:2064\u20132077","journal-title":"Hepatology"},{"key":"3893_CR8","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","volume":"8","author":"R Bellomo","year":"2004","unstructured":"Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup (2004) Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care 8:R204\u2013R212","journal-title":"Crit Care"},{"issue":"Suppl1","key":"3893_CR9","first-page":"1","volume":"2","author":"JA Kellum","year":"2012","unstructured":"Kellum JA, Lameire N, KDIGO AKI Guideline Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int 2[Suppl1]:1\u2013124","journal-title":"Kidney Int"},{"key":"3893_CR10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ckj\/sfs160","volume":"6","author":"JA Lopes","year":"2013","unstructured":"Lopes JA, Jorge S (2013) The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review. Clin Kidney J 6:8\u201314","journal-title":"Clin Kidney J"},{"key":"3893_CR11","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/cc11188","volume":"16","author":"MK Nadim","year":"2012","unstructured":"Nadim MK, Kellum JA, Davenport A, Wong F, Davis C, Pannu N, Tolwani A, Bellomo R, Genyk YS, ADQI Workgroup (2012) Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 16:R23","journal-title":"Crit Care"},{"key":"3893_CR12","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","volume":"62","author":"P Angeli","year":"2015","unstructured":"Angeli P, Gin\u00e8s P, Wong F, Bernardi M, Boyer TD, Gerbes A, Moreau R, Jalan R, Sarin SK, Piano S (2015) Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. J Hepatol 62:968\u2013974","journal-title":"J Hepatol"},{"key":"3893_CR13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/labinvest.2008.124","volume":"89","author":"HT Lee","year":"2009","unstructured":"Lee HT, Park SW, Kim M, D\u2019Agati VD (2009) Acute kidney injury after hepatic ischemia and reperfusion injury in mice. Lab Invest 89:196\u2013208","journal-title":"Lab Invest"},{"key":"3893_CR14","doi-asserted-by":"crossref","first-page":"376795","DOI":"10.1155\/2014\/376795","volume":"2014","author":"AA Qasem","year":"2014","unstructured":"Qasem AA, Farag SE, Hamed E, Emara M, Bihery A, Pasha H (2014) Urinary biomarkers of acute kidney injury in patients with liver cirrhosis. ISRN Nephrol 2014:376795","journal-title":"ISRN Nephrol"},{"key":"3893_CR15","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.20993","volume":"43","author":"Y Iwakiri","year":"2006","unstructured":"Iwakiri Y, Groszmann RJ (2006) The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 43:S121\u2013S131","journal-title":"Hepatology"},{"key":"3893_CR16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"P Sort","year":"1999","unstructured":"Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Gin\u00e8s P, Rod\u00e9s J (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341:403\u2013409","journal-title":"N Engl J Med"},{"key":"3893_CR17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jhep.2009.11.025","volume":"52","author":"C Francoz","year":"2010","unstructured":"Francoz C, Glotz D, Moreau R, Durand F (2010) The evaluation of renal function and disease in patients with cirrhosis. J Hepatol 52:605\u2013613","journal-title":"J Hepatol"},{"key":"3893_CR18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2010.02.018","volume":"53","author":"E Cholongitas","year":"2010","unstructured":"Cholongitas E, Xirouchakis E, Garcovich M, Burroughs AK (2010) Evaluation of renal function in patients with cirrhosis. J Hepatol 53:589","journal-title":"J Hepatol"},{"key":"3893_CR19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1001\/archinte.1988.00380060077017","volume":"148","author":"T Takabatake","year":"1988","unstructured":"Takabatake T, Ohta H, Ishida Y, Hara H, Ushiogi Y, Hattori N (1988) Low serum creatinine levels in severe hepatic disease. Arch Intern Med 148:1313\u20131315","journal-title":"Arch Intern Med"},{"key":"3893_CR20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/cc8855","volume":"4","author":"A Slack","year":"2010","unstructured":"Slack A, Yeoman A, Wendon J (2010) Renal dysfunction in chronic liver disease. Crit Care 4:214","journal-title":"Crit Care"},{"key":"3893_CR21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2362.1990.tb01800.x","volume":"20","author":"P Angeli","year":"1990","unstructured":"Angeli P, Gatta A, Caregaro L, Menon F, Sacerdoti D, Merkel C, Rondana M, de Toni R, Ruol A (1990) Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance. Eur J Clin Invest 20:111\u2013117","journal-title":"Eur J Clin Invest"},{"key":"3893_CR22","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/gut.51.5.736","volume":"51","author":"G Sanso\u00e8","year":"2002","unstructured":"Sanso\u00e8 G, Biava AM, Silvano S, Ferrari A, Rosina F, Smedile A, Touscoz A, Bonardi L, Rizzetto M (2002) Renal tubular events following passage from the supine to the standing position in patients with compensated liver cirrhosis: loss of tubuloglomerular feedback. Gut 51:736\u2013741","journal-title":"Gut"},{"key":"3893_CR23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gutjnl-2011-301255","volume":"62","author":"CD Tsien","year":"2013","unstructured":"Tsien CD, Rabie R, Wong F (2013) Acute kidney injury in decompensated cirrhosis. Gut 62:131\u2013137","journal-title":"Gut"},{"key":"3893_CR24","first-page":"1310","volume":"56","author":"F Salerno","year":"2007","unstructured":"Salerno F, Gerbes A, Gin\u00e8s P, Wong F, Arroyo V (2007) Diagnosis, prevention and reatment of hepatorenal syndrome in cirrhosis. Gut 56:1310\u20131318","journal-title":"Gut"},{"key":"3893_CR25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MOG.0000000000000168","volume":"31","author":"NH Urrunaga","year":"2015","unstructured":"Urrunaga NH, Mindikoglu AL, Rockey DC (2015) Renal dysfunction in cirrhosis. Curr Opin Gastroenterol 31:215\u2013223","journal-title":"Curr Opin Gastroenterol"},{"key":"3893_CR26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s12072-013-9456-x","volume":"7","author":"SL Nayak","year":"2013","unstructured":"Nayak SL, Maiwall R, Nandwani A, Ramanarayanan S, Mathur RP, Kumar R, Sarin SK, Vashishtha C (2013) Management of acute kidney injury in cirrhosis. Hepatol Int 7:813\u2013819","journal-title":"Hepatol Int"},{"key":"3893_CR27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","volume":"140","author":"M Mart\u00edn-Llah\u00ed","year":"2011","unstructured":"Mart\u00edn-Llah\u00ed M, Guevara M, Torre A, Fagundes C, Restuccia T, Gilabert R, Sol\u00e1 E, Pereira G, Marinelli M, Pavesi M, Fern\u00e1ndez J, Rod\u00e9s J, Arroyo V, Gin\u00e8s P (2011) Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology 140:488\u2013496.e4","journal-title":"Gastroenterology"},{"key":"3893_CR28","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1053\/j.gastro.2013.08.051","volume":"145","author":"F Wong","year":"2013","unstructured":"Wong F, O\u2019Leary JG, Reddy KR, Patton H, Kamath PS, Fallon MB, Garcia-Tsao G, Subramanian RM, Malik R, Maliakkal B, Thacker LR, Bajaj JS, North American Consortium for Study of End-Stage Liver Disease (2013) New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology 145:1280\u20131288.e1","journal-title":"Gastroenterology"},{"key":"3893_CR29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","volume":"45","author":"S Fasolato","year":"2007","unstructured":"Fasolato S, Angeli P, Dallagnese L, Maresio G, Zola E, Mazza E, Salinas F, Don\u00e0 S, Fagiuoli S, Sticca A, Zanus G, Cillo U, Frasson I, Destro C, Gatta A (2007) Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology 45:223\u2013229","journal-title":"Hepatology"},{"key":"3893_CR30","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","volume":"60","author":"JM Belcher","year":"2014","unstructured":"Belcher JM, Sanyal AJ, Peixoto AJ, Perazella MA, Lim J, Thiessen-Philbrook H, Ansari N, Coca SG, Garcia-Tsao G, Parikh CR, TRIBE\u2013AKI Consortium (2014) Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology 60:622\u2013632","journal-title":"Hepatology"},{"key":"3893_CR31","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, Gerbes A, Wendon J, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M, Arroyo V, CANONIC Study Investigators of the EASL\u2013CLIF Consortium (2013) Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 144:1426\u20131437","journal-title":"Gastroenterology"},{"key":"3893_CR32","first-page":"295","volume":"10","author":"LE Zamora Nava","year":"2014","unstructured":"Zamora Nava LE, Aguirre Valadez J, Ch\u00e1vez-Tapia NC, Torre A (2014) Acute-on-chronic liver failure: a review. Ther Clin Risk Manag 10:295\u2013303","journal-title":"Ther Clin Risk Manag"},{"key":"3893_CR33","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/j.jhep.2014.11.045","volume":"62","author":"V Arroyo","year":"2015","unstructured":"Arroyo V, Moreau R, Jalan R, Gin\u00e8s P, EASL\u2013CLIF Consortium CANONIC Study (2015) Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis. J Hepatol 62:S131\u2013S143","journal-title":"J Hepatol"},{"key":"3893_CR34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MPG.0000000000001179","volume":"63","author":"S Alam","year":"2016","unstructured":"Alam S, Lal BB, Sood V, Rawat D (2016) Pediatric acute-on-chronic liver failure in a specialized liver unit: prevalence, profile, outcome, and predictive factors. J Pediatr Gastroenterol Nutr 63:400\u2013405","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3893_CR35","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","volume":"23","author":"V Arroyo","year":"1996","unstructured":"Arroyo V, Gin\u00e8s P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Sch\u00f6lmerich J (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International ascites club. Hepatology 23:164\u2013176","journal-title":"Hepatology"},{"key":"3893_CR36","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.4254\/wjh.v8.i25.1075","volume":"8","author":"JP Arab","year":"2016","unstructured":"Arab JP, Claro JC, Arancibia JP, Contreras J, G\u00f3mez F, Mu\u00f1oz C, Nazal L, Roessler E, Wolff R, Arrese M, Ben\u00edtez C (2016) Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: a Delphi technique-based consensus. World J Hepatol 8:1075\u20131086","journal-title":"World J Hepatol"},{"key":"3893_CR37","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","volume":"362","author":"P Gin\u00e8s","year":"2003","unstructured":"Gin\u00e8s P, Guevara M, Arroyo V, Rod\u00e9s J (2003) Hepatorenal syndrome. Lancet 362:1819\u20131827","journal-title":"Lancet"},{"key":"3893_CR38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-2006-947293","volume":"26","author":"V Arroyo","year":"2006","unstructured":"Arroyo V, Terra C, Gin\u00e8s P (2006) New treatments of hepatorenal syndrome. Semin Liver Dis 26:254\u2013264","journal-title":"Semin Liver Dis"},{"key":"3893_CR39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2008-1040323","volume":"28","author":"V Arroyo","year":"2008","unstructured":"Arroyo V, Fernandez J, Gin\u00e8s P (2008) Pathogenesis and treatment of hepatorenal syndrome. Semin Liver Dis 28:81\u201395","journal-title":"Semin Liver Dis"},{"key":"3893_CR40","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4254\/wjh.v7.i7.993","volume":"7","author":"N Rognant","year":"2015","unstructured":"Rognant N (2015) Acute kidney injury in patients with chronic liver disease. World J Hepatol 7:993\u20131000","journal-title":"World J Hepatol"},{"key":"3893_CR41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/157016111201140327163930","volume":"12","author":"B Barbano","year":"2014","unstructured":"Barbano B, Sardo L, Gigante A, Gasperini ML, Liberatori M, Giraldi GDL, Lacanna A, Amoroso A, Cianci R (2014) Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs. Curr Vasc Pharmacol 12:125\u2013135","journal-title":"Curr Vasc Pharmacol"},{"key":"3893_CR42","first-page":"1562","volume":"175","author":"M Egerod Israelsen","year":"2013","unstructured":"Egerod Israelsen M, Gluud LL, Bendtsen F, M\u00f8ller S, Krag AA (2013) Hepatorenal syndrome: diagnosis, treatment and prevention. Ugeskr Laeger 175:1562\u20131566","journal-title":"Ugeskr Laeger"},{"key":"3893_CR43","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.jpedsurg.2011.04.013","volume":"46","author":"M Davenport","year":"2011","unstructured":"Davenport M, Ong E, Sharif K, Alizai N, McClean P, Hadzic N, Kelly DA (2011) Biliary atresia in England and Wales: results of centralization and new benchmark. J Pediatr Surg 46:1689\u20131694","journal-title":"J Pediatr Surg"},{"key":"3893_CR44","doi-asserted-by":"crossref","first-page":"132089","DOI":"10.5402\/2012\/132089","volume":"2012","author":"BE Wildhaber","year":"2012","unstructured":"Wildhaber BE (2012) Biliary atresia: 50 years after the first Kasai. ISRN Surg 2012:132089","journal-title":"ISRN Surg"},{"key":"3893_CR45","first-page":"11","volume":"28","author":"CK Ng","year":"2007","unstructured":"Ng CK, Chan MH, Tai MH, Lam CW (2007) Hepatorenal syndrome. Clin Biochem Rev 28:11\u201317","journal-title":"Clin Biochem Rev"},{"key":"3893_CR46","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/MPG.0b013e3181d60e73","volume":"51","author":"N Yousef","year":"2010","unstructured":"Yousef N, Habes D, Ackermann O, Durand P, Bernard O, Jacquemin E (2010) Hepatorenal syndrome: diagnosis and effect of terlipressin therapy in 4 pediatric patients. J Pediatr Gastroenterol Nutr 51:100\u2013102","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3893_CR47","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.cgh.2010.03.029","volume":"8","author":"S Montoliu","year":"2010","unstructured":"Montoliu S, Ballest\u00e9 B, Planas R, Alvarez MA, Rivera M, Miquel M, Masnou H, Cirera I, Morillas RM, Coll S, Sala M, Garc\u00eda-Retortillo M, Ca\u00f1ete N, Sol\u00e0 R (2010) Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites. Clin Gastroenterol Hepatol 8:616\u2013622 quiz e80","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3893_CR48","first-page":"352","volume":"4","author":"K Fukazawa","year":"2013","unstructured":"Fukazawa K, Lee HT (2013) Updates on hepato-renal syndrome. J Anesth Clin Res 4:352","journal-title":"J Anesth Clin Res"},{"key":"3893_CR49","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/BF02777753","volume":"27","author":"S Sugano","year":"1992","unstructured":"Sugano S (1992) Endotoxin levels in cirrhotic rats with sterile and infected ascites. Gastroenterol Jpn 27:348\u2013353","journal-title":"Gastroenterol Jpn"},{"key":"3893_CR50","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1053\/jhep.2003.09039","volume":"38","author":"R Wiest","year":"2003","unstructured":"Wiest R, Cadelina G, Milstien S, McCuskey RS, Garcia-Tsao G, Groszmann RJ (2003) Bacterial translocation up-regulates GTP-cyclohydrolase I in mesenteric vasculature of cirrhotic rats. Hepatology 38:1508\u20131515","journal-title":"Hepatology"},{"issue":"68","key":"3893_CR51","doi-asserted-by":"publisher","first-page":"re2","DOI":"10.1126\/scisignal.268re2","volume":"2","author":"A. K. Mustafa","year":"2009","unstructured":"Mustafa AK, Gadalla MM, Snyder SH (2009) Signaling by gasotransmitters. Sci Signal 2(68):re2. https:\/\/doi.org\/10.1126\/scisignal.268re2","journal-title":"Science Signaling"},{"key":"3893_CR52","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.3748\/wjg.v18.i24.3035","volume":"18","author":"M Hartleb","year":"2012","unstructured":"Hartleb M (2012) Kidneys in chronic liver diseases. World J Gastroenterol 18:3035","journal-title":"World J Gastroenterol"},{"key":"3893_CR53","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/hep.1840200538","volume":"20","author":"RJ Groszmann","year":"1994","unstructured":"Groszmann RJ (1994) Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 20:1359\u20131363","journal-title":"Hepatology"},{"key":"3893_CR54","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/0016-5085(93)91026-E","volume":"104","author":"F Wong","year":"1993","unstructured":"Wong F, Massie D, Colman J, Dudley F (1993) Glomerular hyperfiltration in patients with well-compensated alcoholic cirrhosis. Gastroenterology 104:884\u2013889","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"3893_CR55","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0168-8278(03)00007-2","volume":"38","author":"V Arroyo","year":"2003","unstructured":"Arroyo V, Colmenero J (2003) Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol 38[Suppl 1]:S69\u2013S89","journal-title":"J Hepatol"},{"key":"3893_CR56","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(05)70238-5","volume":"365","author":"N Lameire","year":"2005","unstructured":"Lameire N, Van Biesen W, Vanholder R (2005) Acute renal failure. Lancet 365:417\u2013430","journal-title":"Lancet"},{"key":"3893_CR57","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/MCC.0b013e328332f6cf","volume":"15","author":"M Dorze Le","year":"2009","unstructured":"Le Dorze M, Legrand M, Payen D, Ince C (2009) The role of the microcirculation in acute kidney injury. Curr Opin Crit Care 15:503\u2013508","journal-title":"Curr Opin Crit Care"},{"key":"3893_CR58","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1172\/JCI45161","volume":"121","author":"JV Bonventre","year":"2011","unstructured":"Bonventre JV, Yang L (2011) Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 121:4210\u20134221","journal-title":"J Clin Invest"},{"key":"3893_CR59","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4254\/wjh.v2.i6.208","volume":"2","author":"M Martell","year":"2010","unstructured":"Martell M, Coll M, Ezkurdia N, Raurell I, Genesc\u00e0 J (2010) Physiopathology of splanchnic vasodilation in portal hypertension. World J Hepatol 2:208\u2013220","journal-title":"World J Hepatol"},{"key":"3893_CR60","first-page":"31","volume":"28","author":"G Fede","year":"2015","unstructured":"Fede G, Privitera G, Tomaselli T, Spadaro L, Purrello F (2015) Cardiovascular dysfunction in patients with liver cirrhosis. Ann Gastroenterol 28:31\u201340","journal-title":"Ann Gastroenterol"},{"key":"3893_CR61","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0735-1097(84)80245-4","volume":"3","author":"SS Ahmed","year":"1984","unstructured":"Ahmed SS, Howard M, ten Hove W, Leevy CM, Regan TJ (1984) Cardiac function in alcoholics with cirrhosis: absence of overt cardiomyopathy\u2014myth or fact? J Am Coll Cardiol 3:696\u2013702","journal-title":"J Am Coll Cardiol"},{"key":"3893_CR62","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gut.2006.112177","volume":"57","author":"S M\u00f8ller","year":"2008","unstructured":"M\u00f8ller S, Henriksen JH (2008) Cardiovascular complications of cirrhosis. Gut 57:268\u2013278","journal-title":"Gut"},{"key":"3893_CR63","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.25573","volume":"55","author":"G Fede","year":"2012","unstructured":"Fede G, Spadaro L, Tomaselli T, Privitera G, Germani G, Tsochatzis E, Thomas M, Bouloux PM, Burroughs AK, Purrello F (2012) Adrenocortical dysfunction in liver disease: a systematic review. Hepatology 55:1282\u20131291","journal-title":"Hepatology"},{"key":"3893_CR64","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3748\/wjg.v19.i4.445","volume":"19","author":"A Trifan","year":"2013","unstructured":"Trifan A, Chiriac S, Stanciu C (2013) Update on adrenal insufficiency in patients with liver cirrhosis. World J Gastroenterol 19:445\u2013456","journal-title":"World J Gastroenterol"},{"key":"3893_CR65","first-page":"2523","volume":"6","author":"Y Chang","year":"2013","unstructured":"Chang Y, Qi X, Li Z, Wang F, Wang S, Zhang Z, Xiao C, Ding T, Yang C (2013) Hepatorenal syndrome: insights into the mechanisms of intra-abdominal hypertension. Int J Clin Exp Pathol 6:2523\u20132528","journal-title":"Int J Clin Exp Pathol"},{"key":"3893_CR66","first-page":"2218","volume":"85","author":"Y Ma","year":"2005","unstructured":"Ma Y, Qian C, Xie F, Zhou F, Pan L, Song Q (2005) Acute renal failure due to abdominal compartment syndrome. Zhonghua Yi Xue Za Zhi 85:2218\u20132220","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"3893_CR67","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ki.2013.78","volume":"84","author":"CM Slambrouck van","year":"2013","unstructured":"van Slambrouck CM, Salem F, Meehan SM, Chang A (2013) Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction. Kidney Int 84:192\u2013197","journal-title":"Kidney Int"},{"key":"3893_CR68","doi-asserted-by":"crossref","first-page":"667","DOI":"10.14740\/jocmr2261w","volume":"7","author":"TG Romano","year":"2015","unstructured":"Romano TG, Vieira Junior JM (2015) Do biliary salts have role on acute kidney injury development? J Clin Med Res 7:667\u2013671","journal-title":"J Clin Med Res"},{"key":"3893_CR69","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1157\/13128301","volume":"31","author":"J Fern\u00e1ndez","year":"2008","unstructured":"Fern\u00e1ndez J, Fern\u00e1ndez-Balsells M, Acevedo J, Arroyo V (2008) Adrenal insufficiency in cirrhosis. Gastroenterol Hepatol 31:606\u2013611","journal-title":"Gastroenterol Hepatol"},{"key":"3893_CR70","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.ajkd.2016.08.023","volume":"69","author":"J Aniort","year":"2017","unstructured":"Aniort J, Poyet A, Kemeny J-L, Philipponnet C, Heng A-E (2017) Bile cast nephropathy caused by obstructive cholestasis. Am J Kidney Dis 69:143\u2013146","journal-title":"Am J Kidney Dis"},{"key":"3893_CR71","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1523-1755.2004.761_2.x","volume":"66","author":"JV Bonventre","year":"2004","unstructured":"Bonventre JV, Zuk A (2004) Ischemic acute renal failure: an inflammatory disease? Kidney Int 66:480\u2013405","journal-title":"Kidney Int"},{"key":"3893_CR72","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.semnephrol.2015.01.010","volume":"35","author":"SK Verma","year":"2015","unstructured":"Verma SK, Molitoris BA (2015) Renal endothelial injury and microvascular dysfunction in acute kidney injury. Semin Nephrol 35:96\u2013107","journal-title":"Semin Nephrol"},{"key":"3893_CR73","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","volume":"8","author":"RW Schrier","year":"1988","unstructured":"Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rod\u00e9s J (1988) Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8:1151\u20131157","journal-title":"Hepatology"},{"key":"3893_CR74","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","volume":"57","author":"JM Belcher","year":"2013","unstructured":"Belcher JM, Garcia-Tsao G, Sanyal AJ, Bhogal H, Lim JK, Ansari N, Coca SG, Parikh CR, TRIBE-AKI Consortium (2013) Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology 57:753\u2013762","journal-title":"Hepatology"},{"key":"3893_CR75","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1681\/ASN.2011090907","volume":"23","author":"JL Koyner","year":"2012","unstructured":"Koyner JL, Garg AX, Coca SG, Sint K, Thiessen-Philbrook H, Patel UD, Shlipak MG, Parikh CR, TRIBE-AKI Consortium (2012) Biomarkers predict progression of acute kidney injury after cardiac surgery. J Am Soc Nephrol 23:905\u2013914","journal-title":"J Am Soc Nephrol"},{"key":"3893_CR76","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ccc.2015.06.009","volume":"31","author":"CJ Karvellas","year":"2015","unstructured":"Karvellas CJ, Durand F, Nadim MK (2015) Acute kidney injury in cirrhosis. Crit Care Clin 31:737\u2013750","journal-title":"Crit Care Clin"},{"key":"3893_CR77","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0167-4838(00)00147-3","volume":"1482","author":"DR Flower","year":"2000","unstructured":"Flower DR (2000) Experimentally determined lipocalin structures. Biochim Biophys Acta 1482:46\u201356","journal-title":"Biochim Biophys Acta"},{"key":"3893_CR78","volume":"2013","author":"E Tsigou","year":"2013","unstructured":"Tsigou E, Psallida V, Demponeras C, Boutzouka E, Baltopoulos G (2013) Role of new biomarkers: functional and structural damage. Crit Care Res Pract 2013:e361078","journal-title":"Crit Care Res Pract"},{"key":"3893_CR79","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jacc.2010.11.051","volume":"57","author":"M Haase","year":"2011","unstructured":"Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, Krawczeski CD, Koyner JL, Murray P, Zappitelli M, Goldstein SL, Makris K, Ronco C, Martensson J, Martling CR, Venge P, Siew E, Ware LB, Ikizler TA, Mertens PR (2011) The outcome of neutrophil gelatinase-associated Lipocalin (NGAL)-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol 57:1752\u20131761","journal-title":"J Am Coll Cardiol"},{"key":"3893_CR80","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","volume":"57","author":"EC Verna","year":"2012","unstructured":"Verna EC, Brown RS, Farrand E, Pichardo EM, Forster CS, Sola-Del Valle DA, Adkins SH, Sise ME, Oliver JA, Radhakrishnan J, Barasch JM, Nickolas TL (2012) Urinary neutrophil gelatinase-associated Lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci 57:2362\u20132370","journal-title":"Dig Dis Sci"},{"key":"3893_CR81","doi-asserted-by":"crossref","unstructured":"S\u00e9ronie-Vivien S, Delanaye P, Pi\u00e9roni L, Mariat C, Froissart M, Cristol J-P, SFBC \"Biology of Renal Function and Renal Failure\" working group (2008) Cystatin C: current position and future prospects. Clin Chem Lab Med 46:1664\u20131686","DOI":"10.1515\/CCLM.2008.336"},{"key":"3893_CR82","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1515\/CCLM.2006.050","volume":"44","author":"M Conti","year":"2006","unstructured":"Conti M, Moutereau S, Zater M, Lallali K, Durrbach A, Manivet P, Eschw\u00e8ge P, Loric S (2006) Urinary cystatin C as a specific marker of tubular dysfunction. Clin Chem Lab Med 44:288\u2013291","journal-title":"Clin Chem Lab Med"},{"key":"3893_CR83","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3350\/kjhep.2010.16.3.301","volume":"16","author":"MY Chung","year":"2010","unstructured":"Chung MY, Jun DW, Sung SA (2010) Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis. Korean J Hepatol 16:301\u2013307","journal-title":"Korean J Hepatol"},{"key":"3893_CR84","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/lt.20330","volume":"11","author":"M Samyn","year":"2005","unstructured":"Samyn M, Cheeseman P, Bevis L, Taylor R, Samaroo B, Buxton-Thomas M, Heaton N, Rela M, Mieli-Vergani G, Dhawan A (2005) Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl 11:344\u2013349","journal-title":"Liver Transpl"},{"key":"3893_CR85","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00467-012-2341-3","volume":"28","author":"EJ Nehus","year":"2013","unstructured":"Nehus EJ, Laskin BL, Kathman TI, Bissler JJ (2013) Performance of cystatin C-based equations in a pediatric cohort at high risk of kidney injury. Pediatr Nephrol 28:453\u2013461","journal-title":"Pediatr Nephrol"},{"key":"3893_CR86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00148581-200608010-00001","volume":"8","author":"D Debray","year":"2006","unstructured":"Debray D, Yousef N, Durand P (2006) New management options for end-stage chronic liver disease and acute liver failure: potential for pediatric patients. Paediatr Drugs 8:1\u201313","journal-title":"Paediatr Drugs"},{"key":"3893_CR87","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/j.gastro.2005.04.016","volume":"129","author":"KA Tazi","year":"2005","unstructured":"Tazi KA, Moreau R, Herv\u00e9 P, Dauvergne A, Cazals-Hatem D, Bert F, Poirel O, Rabiller A, Lebrec D (2005) Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: role of Akt signaling. Gastroenterology 129:303\u2013314","journal-title":"Gastroenterology"},{"key":"3893_CR88","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","volume":"133","author":"J Fern\u00e1ndez","year":"2007","unstructured":"Fern\u00e1ndez J, Navasa M, Planas R, Montoliu S, Monfort D, Soriano G, Vila C, Pardo A, Quintero E, Vargas V, Such J, Gin\u00e8s P, Arroyo V (2007) Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 133:818\u2013824","journal-title":"Gastroenterology"},{"key":"3893_CR89","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1097\/MCG.0b013e31822e8e12","volume":"46","author":"JR Carvalho de","year":"2012","unstructured":"de Carvalho JR, Villela-Nogueira CA, Luiz RR, Guzzo PL, da Silva Rosa JM, Rocha E, Moraes Coelho HS, de Mello Perez R (2012) Acute kidney injury network criteria as a predictor of hospital mortality in cirrhotic patients with ascites. J Clin Gastroenterol 46:e21\u2013e26","journal-title":"J Clin Gastroenterol"},{"key":"3893_CR90","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s00134-008-1253-y","volume":"35","author":"A Umgelter","year":"2009","unstructured":"Umgelter A, Reindl W, Franzen M, Lenhardt C, Huber W, Schmid RM (2009) Renal resistive index and renal function before and after paracentesis in patients with hepatorenal syndrome and tense ascites. Intensive Care Med 35:152\u2013156","journal-title":"Intensive Care Med"},{"key":"3893_CR91","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/cc6765","volume":"12","author":"A Umgelter","year":"2008","unstructured":"Umgelter A, Reindl W, Wagner KS, Franzen M, Stock K, Schmid RM, Huber W (2008) Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial. Crit Care 12:R4","journal-title":"Crit Care"},{"key":"3893_CR92","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000199198","volume":"31","author":"M Bernardi","year":"1985","unstructured":"Bernardi M, Servadei D, Trevisani F, Rusticali AG, Gasbarrini G (1985) Importance of plasma aldosterone concentration on the natriuretic effect of spironolactone in patients with liver cirrhosis and ascites. Digestion 31:189\u2013193","journal-title":"Digestion"},{"key":"3893_CR93","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra035021","volume":"350","author":"P Gin\u00e8s","year":"2004","unstructured":"Gin\u00e8s P, C\u00e1rdenas A, Arroyo V, Rod\u00e9s J (2004) Management of Cirrhosis and Ascites. N Engl J Med 350:1646\u20131654","journal-title":"N Engl J Med"},{"key":"3893_CR94","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jhep.2012.12.020","volume":"58","author":"P Bellot","year":"2013","unstructured":"Bellot P, Welker M-W, Soriano G, von Schaewen M, Appenrodt B, Wiest R, Whittaker S, Tzonev R, Handshiev S, Verslype C, Moench C, Zeuzem S, Sauerbruch T, Guarner C, Schott E, Johnson N, Petrov A, Katzarov K, Nevens F, Zapater P, Such J (2013) Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study. J Hepatol 58:922\u2013927","journal-title":"J Hepatol"},{"key":"3893_CR95","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.03.001","volume":"53","author":"European Association for the Study of the Liver","year":"2010","unstructured":"European Association for the Study of the Liver (2010) EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 53:397\u2013417","journal-title":"J Hepatol"},{"key":"3893_CR96","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ejim.2013.05.015","volume":"24","author":"P Caraceni","year":"2013","unstructured":"Caraceni P, Domenicali M, Tovoli A, Napoli L, Ricci CS, Tufoni M, Bernardi M (2013) Clinical indications for the albumin use: still a controversial issue. Eur J Intern Med 24:721\u2013728","journal-title":"Eur J Intern Med"},{"key":"3893_CR97","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.26338","volume":"58","author":"R Garcia-Martinez","year":"2013","unstructured":"Garcia-Martinez R, Caraceni P, Bernardi M, Gines P, Arroyo V, Jalan R (2013) Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology 58:1836\u20131846","journal-title":"Hepatology"},{"key":"3893_CR98","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/157488611798280906","volume":"6","author":"A Facciorusso","year":"2011","unstructured":"Facciorusso A, Nacchiero MC, Rosania R, Laonigro G, Longo N, Panella C, Ierardi E (2011) The use of human albumin for the treatment of ascites in patients with liver cirrhosis: item of safety, facts, controversies and perspectives. Curr Drug Saf 6:267\u2013274","journal-title":"Curr Drug Saf"},{"key":"3893_CR99","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ncpgasthep0680","volume":"4","author":"F Wong","year":"2007","unstructured":"Wong F (2007) Drug insight: the role of albumin in the management of chronic liver disease. Nat Clin Pract Gastroenterol Hepatol 4:43\u201351","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"3893_CR100","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/cc2945","volume":"9","author":"A Delmas","year":"2004","unstructured":"Delmas A, Leone M, Rousseau S, Alban\u00e8se J, Martin C (2004) Clinical review: vasopressin and terlipressin in septic shock patients. Crit Care 9:212","journal-title":"Crit Care"},{"key":"3893_CR101","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","volume":"18","author":"P Solanki","year":"2003","unstructured":"Solanki P, Chawla A, Garg R, Gupta R, Jain M, Sarin SK (2003) Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol 18:152\u2013156","journal-title":"J Gastroenterol Hepatol"},{"key":"3893_CR102","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jcrc.2013.02.016","volume":"28","author":"N Fayed","year":"2013","unstructured":"Fayed N, Refaat EK, Yassein TE, Alwaraqy M (2013) Effect of perioperative terlipressin infusion on systemic, hepatic, and renal hemodynamics during living donor liver transplantation. J Crit Care 28:775\u2013782","journal-title":"J Crit Care"},{"key":"3893_CR103","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/j.gastro.2009.03.064","volume":"137","author":"AL Gerbes","year":"2009","unstructured":"Gerbes AL, Huber E, G\u00fclberg V (2009) Terlipressin for hepatorenal syndrome: continuous infusion as an alternative to i.V. Bolus administration. Gastroenterology 137:1179 author reply 1179-1181","journal-title":"Gastroenterology"},{"key":"3893_CR104","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","volume":"63","author":"M Cavallin","year":"2016","unstructured":"Cavallin M, Piano S, Romano A, Fasolato S, Frigo AC, Benetti G, Gola E, Morando F, Stanco M, Rosi S, Sticca A, Cillo U, Angeli P (2016) Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study. Hepatology 63:983\u2013992","journal-title":"Hepatology"},{"key":"3893_CR105","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","volume":"134","author":"AJ Sanyal","year":"2008","unstructured":"Sanyal AJ, Boyer T, Garcia-Tsao G, Regenstein F, Rossaro L, Appenrodt B, Blei A, G\u00fclberg V, Sigal S, Teuber P, Terlipressin Study Group (2008) A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 134:1360\u20131368","journal-title":"Gastroenterology"},{"key":"3893_CR106","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","volume":"134","author":"M Mart\u00edn-Llah\u00ed","year":"2008","unstructured":"Mart\u00edn-Llah\u00ed M, P\u00e9pin M-N, Guevara M, D\u00edaz F, Torre A, Monescillo A, Soriano G, Terra C, F\u00e1brega E, Arroyo V, Rod\u00e9s J, Gin\u00e8s P, Investigators TAHRS (2008) Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 134:1352\u20131359","journal-title":"Gastroenterology"},{"key":"3893_CR107","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","volume":"122","author":"R Moreau","year":"2002","unstructured":"Moreau R, Durand F, Poynard T, Duhamel C, Cervoni J-P, Icha\u00ef P, Abergel A, Halimi C, Pauwels M, Bronowicki JP, Giostra E, Fleurot C, Gurnot D, Nouel O, Renard P, Rivoal M, Blanc P, Coumaros D, Ducloux S, Levy S, Pariente A, Perarnau JM, Roche J, Scribe-Outtas M, Valla D, Bernard B, Samuel D, Butel J, Hadengue A, Platek A, Lebrec D, Cadranel JF (2002) Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology 122:923\u2013930","journal-title":"Gastroenterology"},{"key":"3893_CR108","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1365-2036.2006.03086.x","volume":"24","author":"F Fabrizi","year":"2006","unstructured":"Fabrizi F, Dixit V, Martin P (2006) Meta-analysis: terlipressin therapy for the hepatorenal syndrome. Aliment Pharmacol Ther 24:935\u2013944","journal-title":"Aliment Pharmacol Ther"},{"key":"3893_CR109","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","volume":"55","author":"TD Boyer","year":"2011","unstructured":"Boyer TD, Sanyal AJ, Garcia-Tsao G, Blei A, Carl D, Bexon AS, Teuber P, Terlipressin Study Group (2011) Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics. J Hepatol 55:315\u2013321","journal-title":"J Hepatol"},{"key":"3893_CR110","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","volume":"150","author":"TD Boyer","year":"2016","unstructured":"Boyer TD, Sanyal AJ, Wong F, Frederick RT, Lake JR, O\u2019Leary JG, Ganger D, Jamil K, Pappas SC, REVERSE Study Investigators (2016) Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1. Gastroenterology 150:1579\u20131589.e2","journal-title":"Gastroenterology"},{"key":"3893_CR111","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2011.08.020","volume":"56","author":"A C\u00e1rdenas","year":"2012","unstructured":"C\u00e1rdenas A, Gin\u00e8s P, Marotta P, Czerwiec F, Oyuang J, Guevara M, Afdhal NH (2012) Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis. J Hepatol 56:571\u2013578","journal-title":"J Hepatol"},{"key":"3893_CR112","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1097\/CCM.0000000000001826","volume":"44","author":"A Deep","year":"2016","unstructured":"Deep A, Stewart CE, Dhawan A, Douiri A (2016) Effect of continuous renal replacement therapy on outcome in pediatric acute liver failure. Crit Care Med 44:1910\u20131919","journal-title":"Crit Care Med"},{"key":"3893_CR113","first-page":"334","volume":"17","author":"J Yuan","year":"2009","unstructured":"Yuan J, Ye Q, Zhang H, Ming Y, Gui M, Ji Y, Sun J, Wang JW, Ren ZH, Cheng K, Zhao YJ, Sun PL, Wu K, Ji LZ (2009) Evaluation of the renal replacement therapy on the liver transplant patients with acute renal failure. Zhonghua Gan Zang Bing Za Zhi 17:334\u2013337","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"3893_CR114","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00467-012-2348-9","volume":"28","author":"B Schaefer","year":"2013","unstructured":"Schaefer B, Schmitt CP (2013) The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children. Pediatr Nephrol 28:1763\u20131769","journal-title":"Pediatr Nephrol"},{"key":"3893_CR115","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.12688\/f1000research.9623.1","volume":"6","author":"Sara Kathryn Smith","year":"2017","unstructured":"Smith SK, Rosenthal P (2017) Pediatric liver failure: we came, we saw, but have we conquered? [version 1; referees: 2 approved]. F1000Research 2017, 6(F1000 Faculty Rev):1540. https:\/\/doi.org\/10.12688\/f1000research.9623.1","journal-title":"F1000Research"},{"key":"3893_CR116","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00467-011-2066-8","volume":"27","author":"F Paglialonga","year":"2012","unstructured":"Paglialonga F, Ardissino G, Biasuzzi A, Testa S, Edefonti A (2012) Tandem plasma-exchange and haemodialysis in a paediatric dialysis unit. Pediatr Nephrol 27:493\u2013495","journal-title":"Pediatr Nephrol"},{"key":"3893_CR117","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1525-1594.2006.00215.x","volume":"30","author":"P Evenepoel","year":"2006","unstructured":"Evenepoel P, Laleman W, Wilmer A, Claes K, Kuypers D, Bammens B, Nevens F, Vanrenterghem Y (2006) Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. Artif Organs 30:276\u2013284","journal-title":"Artif Organs"},{"key":"3893_CR118","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-2004-826116","volume":"40","author":"S Mitzner","year":"2005","unstructured":"Mitzner S, Klammt S, Stange J, N\u00f6ldge-Schomburg GFE, Schmidt R (2005) Extracorporeal blood purification in severe liver failure with the albumin dialysis MARS\u2014impact on relevant intensive care parameters. Anasthesiol Intensivmed Notfallmed Schmerzther 40:199\u2013206","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"3893_CR119","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","volume":"57","author":"R Ba\u00f1ares","year":"2013","unstructured":"Ba\u00f1ares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, Saliba F, Sauerbruch T, Klammt S, Ockenga J, Pares A, Wendon J, Br\u00fcnnler T, Kramer L, Mathurin P, de la Mata M, Gasbarrini A, M\u00fcllhaupt B, Wilmer A, Laleman W, Eefsen M, Sen S, Zipprich A, Tenorio T, Pavesi M, Schmidt HH, Mitzner S, Williams R, Arroyo V, RELIEF study group (2013) Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology 57:1153\u20131162","journal-title":"Hepatology"},{"key":"3893_CR120","first-page":"17046","volume":"8","author":"GL He","year":"2015","unstructured":"He GL, Feng L, Duan CY, Hu X, Zhou CJ, Cheng Y, Pan MX, Gao Y (2015) Meta-analysis of survival with the molecular adsorbent recirculating system for liver failure. Int J Clin Exp Med 8:17046\u201317054","journal-title":"Int J Clin Exp Med"},{"key":"3893_CR121","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1525-1594.1999.06292.x","volume":"23","author":"D Falkenhagen","year":"1999","unstructured":"Falkenhagen D, Strobl W, Vogt G, Schrefl A, Linsberger I, Gerner FJ, Schoenhofen M (1999) Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances. Artif Organs 23:81\u201386","journal-title":"Artif Organs"},{"key":"3893_CR122","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3748\/wjg.v12.i6.940","volume":"12","author":"K Rifai","year":"2006","unstructured":"Rifai K, Ernst T, Kretschmer U, Haller H, Manns MP, Fliser D (2006) Removal selectivity of Prometheus: a new extracorporeal liver support device. World J Gastroenterol 12:940\u2013944","journal-title":"World J Gastroenterol"},{"key":"3893_CR123","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1744-9987.2006.00354.x","volume":"10","author":"K Rifai","year":"2006","unstructured":"Rifai K, Manns MP (2006) Review article: clinical experience with Prometheus. Ther Apher Dial 10:132\u2013137","journal-title":"Ther Apher Dial"},{"key":"3893_CR124","unstructured":"Deutsches Register Klinischer Studien (DRKS; German Clinical Trials Register) Extracorporeal liver support therapy with Prometheus in patients with hepato-renal syndrome: LUTHER pilot study. Universal Trial Number (UTN): U1111-1115-4645. [Internet]. Available from: https:\/\/drks-neu.uniklinikfreiburg.de\/drks_ web\/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00000441"},{"key":"3893_CR125","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00042737-199710000-00009","volume":"9","author":"CJ Rees","year":"1997","unstructured":"Rees CJ, Rose JD, Record CO, Day CP, Bassendine MF, James OF, Hudson M (1997) Transjugular intrahepatic portosystemic shunt: a limited role in refractory ascites. Eur J Gastroenterol Hepatol 9:969\u2013973","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3893_CR126","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.transproceed.2013.02.127","volume":"45","author":"T Xing","year":"2013","unstructured":"Xing T, Zhong L, Chen D, Peng Z (2013) Experience of combined liver-kidney transplantation for acute-on-chronic liver failure patients with renal dysfunction. Transplant Proc 45:2307\u20132313","journal-title":"Transplant Proc"},{"key":"3893_CR127","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1111\/j.1600-6143.2012.04190.x","volume":"12","author":"MK Nadim","year":"2012","unstructured":"Nadim MK, Sung RS, Davis CL, Andreoni KA, Biggins SW, Danovitch GM, Feng S, Friedewald JJ, Hong JC, Kellum JA, Kim WR, Lake JR, Melton LB, Pomfret EA, Saab S, Genyk YS (2012) Simultaneous liver\u2013kidney transplantation summit: current state and future directions. Am J Transplant 12:2901\u20132908","journal-title":"Am J Transplant"},{"key":"3893_CR128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002248","volume":"14","author":"VK Snowdon","year":"2017","unstructured":"Snowdon VK, Lachlan NJ, Hoy AM, Hadoke PWF, Semple SI, Patel D, Mungall W, Kendall TJ, Thomson A, Lennen RJ, Jansen MA, Moran CM, Pellicoro A, Ramachandran P, Shaw I, Aucott RL, Severin T, Saini R, Pak J, Yates D, Dongre N, Duffield JS, Webb DJ, Iredale JP, Hayes PC, Fallowfield JA (2017) Serelaxin as a potential treatment for renal dysfunction in cirrhosis: preclinical evaluation and results of a randomized phase 2 trial. PLoS Med 14:e1002248","journal-title":"PLoS Med"},{"key":"3893_CR129","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00000658-200109000-00015","volume":"234","author":"AL Singer","year":"2001","unstructured":"Singer AL, Olthoff KM, Kim H, Rand E, Zamir G, Shaked A (2001) Role of plasmapheresis in the management of acute hepatic failure in children. Ann Surg 234:418\u2013424","journal-title":"Ann Surg"},{"key":"3893_CR130","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1665-2681(19)30757-4","volume":"14","author":"NC Chavez-Tapia","year":"2015","unstructured":"Chavez-Tapia NC, Mendiola-Pastrana I, Ornelas-Arroyo VJ, Nore\u00f1a-Herrera C, Vida\u00f1a-Perez D, Delgado-Sanchez G, Uribe M, Barrientos-Gutierrez T (2015) Granulocyte-colony stimulating factor for acute-on-chronic liver failure: systematic review and meta-analysis. Ann Hepatol 14:631\u2013641","journal-title":"Ann Hepatol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-018-3893-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-3893-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-3893-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T02:48:32Z","timestamp":1589856512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-018-3893-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,1]]},"references-count":130,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["3893"],"URL":"https:\/\/doi.org\/10.1007\/s00467-018-3893-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,1]]},"assertion":[{"value":"10 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors state that they have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}